Leveraging CD4 Cell Count at Entry Into Care to Monitor Success of Human Immunodeficiency Virus Prevention, Treatment, and Public Health Programming in the Greater St Louis Area Between 2017 and 2020.
Lindsey M FiliatreauAaloke ModyDaniel VoCory BradleyAditi RamakrishnanJulia LópezJane O'HalloranAnne TrolardWilliam G PowderlyElvin Hsing GengPublished in: Open forum infectious diseases (2023)
CD4 cell count at entry into human immunodeficiency virus (HIV) care is a useful indicator of success of multiple steps in HIV public health programming. We demonstrate that CD4 cell count at care initiation was stable in St Louis between 2017 and 2019 but declined in 2020. Missouri efforts in the Ending the HIV Epidemic plan should focus on rapidly identifying individuals with undiagnosed HIV infection.
Keyphrases
- human immunodeficiency virus
- antiretroviral therapy
- public health
- hepatitis c virus
- hiv infected
- hiv positive
- hiv aids
- single cell
- palliative care
- cell therapy
- healthcare
- quality improvement
- hiv testing
- peripheral blood
- pain management
- stem cells
- south africa
- men who have sex with men
- affordable care act
- replacement therapy